Capricorn Fund Managers Ltd Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001901361
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2025 · 82 positions · Total reported value $414.89M · Top-10 concentration 36.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 75.4% · 43 new · 37 cut · 79 exited
Active Share (vs S&P 500): 89.0% · vs QQQ: 92.5% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -4.8% · vs SPY -6.9% · Prev Value $1.26B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +1.5% · vs SPY -0.6% · Latest Value $1.04B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q4 2025 13F filing, Capricorn Fund Managers Ltd disclosed 82 equity positions with a combined reported value of $414.89M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 36.0% of reported value. HoldingsHub classifies the profile as Small / High Turnover.
The largest disclosed positions as of Q4 2025 were ZYME ($26.93M), WAY ($24.18M), GPCR ($17.57M). By sector, the heaviest allocations are Health Care 31.1%, Technology 18.7%. Versus the prior quarter, allocation shifted toward Other (+15.5pp), Health Care (+4.0pp) and away from Energy (-0.8pp), Consumer Staples (-2.7pp).
Versus the prior quarter, Capricorn Fund Managers Ltd opened 43 new positions, trimmed 37 and fully exited 79, a turnover rate of 75.4% of positions. The portfolio's overlap with the prior quarter was 33% of names.
The largest new positions opened in Q4 2025 were ZYME ($26.93M), GPCR ($17.57M), NUVB ($14.24M).
Of the 79 positions fully exited versus the prior quarter, the largest were VERA ($13.10M), PHR ($11.40M), IONS ($10.65M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2025)
- ZYME ZYMEWORKS INC · $26.93M
- GPCR STRUCTURE THERAPEUTICS INC · $17.57M
- NUVB NUVATION BIO INC · $14.24M
- EXAS EXACT SCIENCES CORP · $9.82M
- BLFS BIOLIFE SOLUTIONS INC · $9.15M
- ALAB ASTERA LABS INC · $8.32M
- SHC SOTERA HEALTH CO · $7.94M
- EA Elanco Animal Health Inc · $7.88M
Fully Exited (vs previous quarter)
- VERA VERA THERAPEUTICS INC · prev qtr: $13.10M
- PHR PHREESIA INC · prev qtr: $11.40M
- IONS IONIS PHARMACEUTICALS INC · prev qtr: $10.65M
- SMMT SUMMIT THERAPEUTICS INC · prev qtr: $10.25M
- AKRO AKERO THERAPEUTICS INC · prev qtr: $7.08M
- ABBV ABBVIE INC · prev qtr: $6.84M
- JNJ JOHNSON & JOHNSON · prev qtr: $6.82M
- SN SHARKNINJA INC · prev qtr: $6.19M · history
Insider Transactions (Form 4)
Latest Capricorn Fund Managers Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Capricorn Fund Managers Ltd is an SEC-registered 13F filer. As of Q2 2026 it reported 168 US equity positions with a combined value of $1.26B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 168 positions · $1.26B reported value (Q2 2026)
- Top 10 holdings = 27.5% of reported value
- Largest position: LPLA (LPL FINL HLDGS INC) at 4.4%
- Average position size: $7.48M
Sector Tilt
- Health Care 21.3%
- Financials 20.5%
- Information Technology 20.3%
- (classified holdings cover 98% of value)
Quarterly Activity
- Q2 2026: 95 new, 32 added, 25 reduced, 41 exited
- 16 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.02M | $26.93M | 6.49% | New | |
| 2 |
|
738.26K | $24.18M | 5.83% | Add | |
| 3 |
|
252.60K | $17.57M | 4.23% | New | |
| 4 |
|
1.59M | $14.24M | 3.43% | New | |
| 5 |
|
28.73K | $13.90M | 3.35% | Add | |
| 6 |
|
107.79K | $11.01M | 2.65% | Add | |
| 7 |
|
47.65K | $11.00M | 2.65% | Add | |
| 8 |
|
238.08K | $10.83M | 2.61% | Add | |
| 9 |
|
96.69K | $9.82M | 2.37% | New | |
| 10 |
|
31.07K | $9.72M | 2.34% | Reduce | |
| 11 |
|
445.50K | $9.67M | 2.33% | Add | |
| 12 |
|
378.55K | $9.15M | 2.21% | New | |
| 13 |
|
50.00K | $8.32M | 2.00% | New | |
| 14 |
|
22.64K | $7.94M | 1.91% | Add | |
| 15 |
|
449.90K | $7.94M | 1.91% | New | |
| 16 |
|
38.55K | $7.88M | 1.90% | New | |
| 17 |
|
25.00K | $7.22M | 1.74% | New | |
| 18 |
|
380.00K | $6.98M | 1.68% | New | |
| 19 |
|
130.00K | $6.94M | 1.67% | New | |
| 20 |
|
75.60K | $6.93M | 1.67% | New | |
| 21 |
|
33.38K | $6.88M | 1.66% | New | |
| 22 |
|
184.10K | $6.88M | 1.66% | Reduce | |
| 23 |
|
60.00K | $6.77M | 1.63% | New | |
| 24 |
|
14.84K | $6.62M | 1.60% | New | |
| 25 |
|
754.91K | $6.30M | 1.52% | Add | |
| 26 |
|
392.90K | $6.20M | 1.49% | Reduce | |
| 27 |
|
151.44K | $6.12M | 1.48% | New | |
| 28 |
|
11.85K | $5.96M | 1.44% | Reduce | |
| 29 |
|
9.02K | $5.95M | 1.44% | Reduce | |
| 30 |
|
85.03K | $5.88M | 1.42% | New | |
| 31 |
|
88.53K | $5.21M | 1.26% | New | |
| 32 |
|
68.46K | $4.94M | 1.19% | Add | |
| 33 |
|
282.49K | $4.87M | 1.17% | New | |
| 34 |
|
70.00K | $4.76M | 1.15% | New | |
| 35 |
|
163.67K | $4.72M | 1.14% | New | |
| 36 |
|
65.09K | $4.44M | 1.07% | Reduce | |
| 37 |
|
29.69K | $4.30M | 1.04% | Add | |
| 38 |
|
165.57K | $4.12M | 0.99% | New | |
| 39 |
|
6.00K | $4.04M | 0.97% | New | |
| 40 |
|
130.39K | $3.94M | 0.95% | New | |
| 41 |
|
16.89K | $3.91M | 0.94% | Reduce | |
| 42 |
|
122.96K | $3.90M | 0.94% | New | |
| 43 |
|
6.60K | $3.84M | 0.93% | New | |
| 44 |
|
26.17K | $3.76M | 0.91% | Reduce | |
| 45 |
|
100.00K | $3.75M | 0.90% | New | |
| 46 |
|
100.00K | $3.74M | 0.90% | New | |
| 47 |
|
8.11K | $3.46M | 0.83% | Reduce | |
| 48 |
|
76.88K | $3.16M | 0.76% | Reduce | |
| 49 |
|
124.61K | $3.01M | 0.72% | New | |
| 50 |
|
210.67K | $3.00M | 0.72% | New | |
FAQ
What did Capricorn Fund Managers Ltd buy in 2025-Q4?
In its 2025-Q4 13F filing, Capricorn Fund Managers Ltd reported 82 equity positions worth $414.89M in aggregate; its largest disclosed positions were ZYME ($26.93M), WAY ($24.18M), GPCR ($17.57M).
How large is Capricorn Fund Managers Ltd's portfolio?
Capricorn Fund Managers Ltd reported $414.89M of long equity holdings across 82 positions as of 2025-Q4. Top-10 holdings account for 36.0% of reported value.
What is Capricorn Fund Managers Ltd's investment style?
HoldingsHub classifies the portfolio as Small / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.